In vitro pharmacology of ICI 198,615: a novel, potent and selective peptide leukotriene antagonist. 1987

D W Snyder, and R E Giles, and R A Keith, and Y K Yee, and R D Krell
Department of Pharmacology, Stuart Pharmaceuticals, Division of ICI Americas Inc., Wilmington, Delaware.

ICI 198,615 is a representative compound from a new class of peptide leukotriene (LT) receptor antagonists. In isolated guinea pig trachea and parenchymal lung strips, ICI 198,615 demonstrated competitive antagonism of the contractile activity of LTD4 and LTE4 with pA2 values of 10.1 to 9.5, respectively. The compound also appeared to antagonize the contractile activity of LTC4 in guinea pig trachea; however, in the presence of an inhibitor of the metabolism of LTC4 to LTD4, ICI 198, 615 provided a pKB value of 5.3, indicating weak antagonism at the LTC4 receptor. ICI 198,615 was also a potent antagonist of LTC4 and LTD4 in isolated human bronchi and pulmonary veins with pKa values of 9.75 +/- 0.32 to 9.20 +/- 0.24, respectively. When evaluated for activity on a broad variety of non-LT receptors, the compound displayed a minimal selectivity of 6310 and a maximal selectivity of greater than 125,000 for the LTE4 receptor. These in vitro studies indicate that ICI 198,615 is the most potent and selective peptide LT receptor antagonist described to date.

UI MeSH Term Description Entries
D007191 Indazoles A group of heterocyclic aromatic organic compounds consisting of the fusion of BENZENE and PYRAZOLES. Indazole
D008297 Male Males
D009130 Muscle, Smooth Unstriated and unstriped muscle, one of the muscles of the internal organs, blood vessels, hair follicles, etc. Contractile elements are elongated, usually spindle-shaped cells with centrally located nuclei. Smooth muscle fibers are bound together into sheets or bundles by reticular fibers and frequently elastic nets are also abundant. (From Stedman, 25th ed) Muscle, Involuntary,Smooth Muscle,Involuntary Muscle,Involuntary Muscles,Muscles, Involuntary,Muscles, Smooth,Smooth Muscles
D011720 Pyrazoles Azoles of two nitrogens at the 1,2 positions, next to each other, in contrast with IMIDAZOLES in which they are at the 1,3 positions.
D011982 Receptors, Prostaglandin Cell surface receptors that bind prostaglandins with high affinity and trigger intracellular changes which influence the behavior of cells. Prostaglandin receptor subtypes have been tentatively named according to their relative affinities for the endogenous prostaglandins. They include those which prefer prostaglandin D2 (DP receptors), prostaglandin E2 (EP1, EP2, and EP3 receptors), prostaglandin F2-alpha (FP receptors), and prostacyclin (IP receptors). Prostaglandin Receptors,Prostaglandin Receptor,Receptor, Prostaglandin,Receptors, Prostaglandins,Prostaglandins Receptors
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D006168 Guinea Pigs A common name used for the genus Cavia. The most common species is Cavia porcellus which is the domesticated guinea pig used for pets and biomedical research. Cavia,Cavia porcellus,Guinea Pig,Pig, Guinea,Pigs, Guinea
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000098 Acetophenones Derivatives of the simplest aromatic ketone acetophenone (of general formula C6H5C(O)CH3).
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

D W Snyder, and R E Giles, and R A Keith, and Y K Yee, and R D Krell
January 1989, European journal of pharmacology,
D W Snyder, and R E Giles, and R A Keith, and Y K Yee, and R D Krell
April 1990, The American review of respiratory disease,
D W Snyder, and R E Giles, and R A Keith, and Y K Yee, and R D Krell
December 1987, The Journal of pharmacology and experimental therapeutics,
D W Snyder, and R E Giles, and R A Keith, and Y K Yee, and R D Krell
January 1988, Annals of the New York Academy of Sciences,
D W Snyder, and R E Giles, and R A Keith, and Y K Yee, and R D Krell
January 1989, Canadian journal of physiology and pharmacology,
D W Snyder, and R E Giles, and R A Keith, and Y K Yee, and R D Krell
February 1995, Canadian journal of physiology and pharmacology,
D W Snyder, and R E Giles, and R A Keith, and Y K Yee, and R D Krell
March 1990, Prostaglandins,
D W Snyder, and R E Giles, and R A Keith, and Y K Yee, and R D Krell
December 1995, British journal of pharmacology,
D W Snyder, and R E Giles, and R A Keith, and Y K Yee, and R D Krell
March 1994, The Journal of pharmacology and experimental therapeutics,
Copied contents to your clipboard!